Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Enlitic›
Analysis
AddedFeb 27, 2023
UpdatedJun 18, 2026
Enlitic

Enlitic

Series B

A pioneer in medical deep learning that leverages algorithms to improve healthcare diagnosis.

HQ
San Francisco, CA, US
Founded
2014
Loading
Overview
Analysis
Compare
Fundraising
Employees
Website

Contents

  1. 01Products & Services
  2. 02Competitive Strengths
  3. 03Competitive Risks
  4. 04Pricing Strategy
  1. 01Products & Services
  2. 02Competitive Strengths
  3. 03Competitive Risks
  4. 04Pricing Strategy

Product Overview

Enlitic is a medical intelligence company that develops AI-based medical imaging solutions to assist physicians in making more accurate diagnoses. Their product is an AI tool that analyzes medical images, such as X-rays, CT scans, and MRIs, using deep learning algorithms to provide insights and recommendations to healthcare providers.

Enlitic's platform can help physicians to identify potential issues that may have been missed by human analysis or to provide a second opinion on a diagnosis. The platform uses advanced algorithms to analyze medical images and can detect patterns and anomalies that may not be immediately visible to the human eye.

The Enlitic platform is designed to be highly accurate and efficient, and it can provide insights and recommendations in real-time, which can help to speed up the diagnosis and treatment process. Additionally, the platform can learn from the input of healthcare professionals, becoming more accurate over time as it receives more data.

Overall, Enlitic's product is a highly sophisticated AI-based medical imaging solution that has the potential to transform the way that healthcare providers diagnose and treat medical conditions. By providing highly accurate insights and recommendations in real-time, Enlitic's platform can help to improve patient outcomes and reduce the time and cost associated with traditional medical imaging and diagnosis methods.

Competitive Advantages

Enlitic's competitive advantage is primarily derived from its sophisticated AI-based medical imaging tools, which provide highly accurate insights and recommendations to healthcare providers in real-time. Below are some factors that contribute to Enlitic's competitive advantage:

Advanced technology: Enlitic's AI-based medical imaging tools utilize advanced deep learning algorithms that are at the forefront of medical imaging technology and have the potential to transform the way that healthcare providers diagnose and treat medical conditions.

High accuracy: Enlitic's platform is designed to be highly accurate, providing actionable insights that may not be immediately visible to the human eye. This high level of accuracy can help to improve patient outcomes and reduce the risk of misdiagnosis or missed diagnoses.

Real-time insights: Enlitic's platform provides actionable insights in real-time, which can help to speed up the diagnosis and treatment process. This can be particularly beneficial in emergency situations, where time is of the essence.

Customization: Enlitic's platform is highly customizable, allowing healthcare providers to tailor the platform to their specific needs and requirements. This customization can help to improve the accuracy and effectiveness of the platform.

Continuous learning: Enlitic's platform is designed to continuously learn and improve from the input of healthcare professionals, becoming more accurate over time as it receives more data. This can help to improve the accuracy and effectiveness of the platform over time.

Overall, Enlitic's sophisticated AI-based medical imaging tools, combined with its high level of accuracy, real-time insights, customization, and continuous learning, provides a significant competitive advantage in the medical imaging and diagnosis market.

Competitive Disadvantages

Enlitic's competitive disadvantages may include the following:

Limited data access: Enlitic's AI-based medical imaging platform requires access to large amounts of high-quality medical data to improve its accuracy and effectiveness. However, access to such data may be limited due to privacy concerns or regulations, which may limit the platform's effectiveness.

Integration challenges: Integrating Enlitic's platform into existing healthcare systems and workflows may be challenging, particularly if the platform requires significant customization or changes to existing processes.

Competition: Enlitic operates in a highly competitive market, with many other companies offering similar AI-based medical imaging solutions. This competition may make it more difficult for Enlitic to differentiate itself and gain market share.

Cost: The cost of Enlitic's platform may be prohibitive for some healthcare providers, particularly smaller organizations or those operating on a tight budget.

Regulatory hurdles: Enlitic's platform may be subject to regulation and oversight by healthcare regulatory bodies, which may make it more difficult and costly to bring the platform to market or to expand its use.

Overall, while Enlitic's AI-based medical imaging tools provide a significant tech-driven competitive advantage, the platform may also face some challenges related to limited data access, integration challenges, competition, cost, and regulatory hurdles.

Pricing Strategy

Enlitic’s specialized AI-based medical imaging solution is likely tailored to the needs of individual healthcare providers, and pricing varies depending on factors such as the number of users, the size of the organization, and the specific features and services that are required.

It is also possible that Enlitic offers a subscription-based model, where small healthcare providers pay a monthly or yearly fee to access the platform and a limited set of features. Alternatively, Enlitic may offer a pay-per-use model, where small healthcare providers pay for each use of the platform or for specific features or services.

Overall, Enlitic's pricing strategy is likely tailored to the specific needs of individual healthcare providers, and may involve a consultation with a sales representative to discuss pricing options and to provide a customized quote based on those needs.